- 24/7 Wall St.•24 days ago
Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some companies made runs in this ...
- Zacks Small Cap Research•27 days ago
By John Vandermosten, CFA NASDAQ:LPCN On June 29, 2016, Lipocine Inc. (NASDAQ:LPCN) announced that the Food and Drug Administration (FDA) had issued a Complete Response Letter (CRL) for LPCN 1021 (Tlando). ...
|Bid||3.60 x 300|
|Ask||3.61 x 700|
|52wk Range||2.51 - 19.23|
|Day's Range||3.53 - 3.72|
|Avg Vol (3m)||525,369|
As of 4:00 PM EDT. Market closed.